Correlation Between Johnson Johnson and AstraZeneca PLC

Can any of the company-specific risk be diversified away by investing in both Johnson Johnson and AstraZeneca PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Johnson Johnson and AstraZeneca PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Johnson Johnson and AstraZeneca PLC, you can compare the effects of market volatilities on Johnson Johnson and AstraZeneca PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Johnson Johnson with a short position of AstraZeneca PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Johnson Johnson and AstraZeneca PLC.

Diversification Opportunities for Johnson Johnson and AstraZeneca PLC

0.49

Correlation Coefficient

Johnson Johnson  AstraZeneca PLC

Very weak diversification

The 3 months correlation between Johnson and AstraZeneca is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and AstraZeneca PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AstraZeneca PLC and Johnson Johnson is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Johnson Johnson are associated (or correlated) with AstraZeneca PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AstraZeneca PLC has no effect on the direction of Johnson Johnson i.e., Johnson Johnson and AstraZeneca PLC go up and down completely randomly.

Pair Corralation between Johnson Johnson and AstraZeneca PLC

Assuming the 90 days trading horizon Johnson Johnson is expected to generate 0.56 times more return on investment than AstraZeneca PLC. However, Johnson Johnson is 1.79 times less risky than AstraZeneca PLC. It trades about -0.11 of its potential returns per unit of risk. AstraZeneca PLC is currently generating about -0.1 per unit of risk. If you would invest  14,943  in Johnson Johnson on September 17, 2024 and sell it today you would lose (985.00) from holding Johnson Johnson or give up 6.59% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Johnson Johnson  vs.  AstraZeneca PLC

Johnson Johnson

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Johnson Johnson has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's forward-looking indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

AstraZeneca PLC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days AstraZeneca PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's technical and fundamental indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Pair Trading with Johnson Johnson and AstraZeneca PLC

The main advantage of trading using opposite Johnson Johnson and AstraZeneca PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Johnson Johnson position performs unexpectedly, AstraZeneca PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AstraZeneca PLC will offset losses from the drop in AstraZeneca PLC's long position.

The idea behind Johnson Johnson and AstraZeneca PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.